:26:01
Just do it.
:26:06
Hart-Mercer Pharmaceuticals...
:26:09
dedicated to making the world
a happier,healthier place.
:26:13
Now and in years ahead,
we will continue our...
:26:17
You are too involved.
There's a reason why they...
:26:19
don't want a primary researcher
conducting his own clinical trial.
:26:23
The man is out of control. Unsuitable.
We'll find another one.
:26:27
We have to give him more time.
I'm increasing the dosage.
:26:30
If you don't like it, you can hand
my resignation in to the board.
:26:37
Be careful. If one threatens to
resign one time too many...
:26:42
they get taken up on it.
:26:43
And now, ladies and gentlemen, Senior
V.P. Of Research and Development...
:26:48
Dr. Arlo Penner.
:27:01
Thank you.
:27:02
Not too long ago, the acronym
SSRI was virtually unheard of.
:27:08
Now, of course, Selective
Seratonin Reuptake Inhibitors...
:27:12
help millions of people
lead better lives.
:27:19
Today, as we speak...
:27:21
a new class of pharmaceuticals
is being developed...
:27:24
that has the potential to
change society as we know it.
:27:30
As you're probably aware,
the reason why Hart-Mercer stock...
:27:34
remains strong within this
volatile market sector...
:27:37
is largely because of Dynax.
:27:40
And I'm pleased to be able
to announce to you that...
:27:43
Dynax has once again
been named...
:27:45
as this year's most
prescribed anti-depressant.
:27:53
So, on behalf of...
:27:56
the board of directors and the
shareholders of Hart-Mercer...